1. Home
  2. UGRO vs EVAX Comparison

UGRO vs EVAX Comparison

Compare UGRO & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo urban-gro Inc.

UGRO

urban-gro Inc.

HOLD

Current Price

$19.00

Market Cap

13.2M

ML Signal

HOLD

EVAX

Evaxion Biotech

HOLD

Current Price

$3.78

Market Cap

31.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UGRO
EVAX
Founded
2014
2008
Country
United States
Denmark
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.2M
31.9M
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
UGRO
EVAX
Price
$19.00
$3.78
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$11.67
AVG Volume (30 Days)
10.3M
31.0K
Earning Date
02-17-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$40,008,850.00
N/A
Revenue This Year
$98.41
N/A
Revenue Next Year
$23.34
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.11
$1.20
52 Week High
$39.68
$12.15

Technical Indicators

Market Signals
Indicator
UGRO
EVAX
Relative Strength Index (RSI) 61.93 51.94
Support Level $0.71 $2.45
Resistance Level $39.68 $4.64
Average True Range (ATR) 6.81 0.34
MACD 1.28 0.01
Stochastic Oscillator 44.90 53.67

Price Performance

Historical Comparison
UGRO
EVAX

About UGRO urban-gro Inc.

Urban-gro Inc operated as an integrated professional services and design-build firm offering architectural, engineering, and construction management solutions to the CEA, industrial, healthcare, and other commercial sectors. The company generated revenue by billing employees time on client projects and provided architectural, engineering, systems procurement and integration, and construction design-build solutions with a single point of accountability. For CEA clients, it developed indoor cultivation facilities for specialty crops, including cannabis and produce such as leafy greens, vegetables, herbs, and berries. Its segments included Equipment Systems (commercial horticulture equipment), Services (design-build services), and Construction Design-Build (general contracting).

About EVAX Evaxion Biotech

Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.

Share on Social Networks: